In a Pharmacy Times interview at the HOPA Annual Meeting 2025, Christine Barrett, PharmD, BCOP, clinical pharmacy specialist at West Virginia University, discussed the advantages of neoadjuvant therapy in melanoma, particularly the use of immunotherapy to leverage the tumor microenvironment and existing T-cell populations before surgery.
Health Professionals
First Patient Receives KSQ-004EX for Advanced Cancer
A phase 1/2 trial evaluating KSQ-004EX, a novel CRISPR-engineered tumor infiltrating lymphocyte (eTIL) therapy, has dosed its first patient with an advanced solid tumor.
Advanced Melanoma at Diagnosis Associated With Several Patient-Specific Factors
Patients with certain sociodemographic factors are significantly more likely to present with advanced-stage melanoma at diagnosis, including those who live farther from treatment centers, those with Medicaid or without insurance, and those from lower-income households, among other factors. These study findings were published in SKIN.
Skin cancer patients given fast-tracked access to ‘revolutionary’ vaccine trial
Source: University Hospital Southampton, April 2025 Patients with advanced melanoma are set to be fast-tracked into clinical trials of a new cancer vaccine following the expansion of a Southampton-run national…
Read More